Surinabant
Alternative Names: SR147778Latest Information Update: 24 Oct 2021
At a glance
- Originator sanofi-aventis
- Class Amides; Drug withdrawal therapies; Obesity therapies; Piperidines; Pyrazoles; Smoking cessation therapies
- Mechanism of Action Cannabinoid receptor CB1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alcoholism; Obesity; Psychotic disorders; Smoking withdrawal